logo-loader
viewAbcam

Abcam shares tumble as outlook misses expectations despite double-digit earnings growth in full year

Despite reporting adjusted earnings growth of 20.5%, the firm saw its shares fall as its 36% margin growth forecast for the new year came in below analyst estimates

Antibodies
Even a final dividend hike to 8.58p from 7.36p wasn't enough to stop the slide

Abcam PLC (LON:ABC) saw its shares take a tumble in early trading Monday despite double-digit growth in its underlying earnings (EBITDA) for the full year after its estimates for the new financial year missed expectations.

The AIM 100 supplier of research tools to the life sciences industry reported adjusted EBITDA for the year of £88.3mln, up 20.5% on the previous year, while revenues climbed 7.4% to £233.2mln (or 10.7% on a constant currency basis).

READ: Abcam forecasts double-digit revenue growth for full-year as it sees product growth across the board

The company also upped its final dividend for the year to 8.58p from 7.36p the year before, increasing its total dividend 17.9% to 12p per share.

The double-digit growth and dividend hike weren’t enough to placate shareholders though, with the stock tumbling 23.3% to 1,137p after Abcam forecast that its adjusted EBITDA margin for the new financial year would be around 36% because of increased investment in its strategic initiatives.

Analysts at City broker Peel Hunt said that margin forecast had come in “well below” their estimates of 39% for the new financial year, while also being less than the margin reported in the results, which grew to 37.9% from 33.8% the previous year.

The broker added that the full year adjusted EBITDA of £88.3mln had come in below analyst estimates of £90.4mln for the period and expected a “significant pull-back” in the share price in response.

 

Quick facts: Abcam

Price: 1288 GBX

AIM:ABC
Market: AIM
Market Cap: £2.65 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Eckoh PLC doubles its US revenues with 'more to come', says...

Eckoh PLC's (LON:ECK) Nik Philpot talks Proactive through their results for the six months to September 2019. The group enjoyed significant commercial traction in the US, where revenues doubled and, since period end, they've landed a deal with an unnamed Fortune 100 retailer. For the group...

9 hours, 47 minutes ago

2 min read